Pressure Biosciences Stock Cash Per Share
| PBIODelisted Stock | USD 0.49 0.00 0.00% |
Pressure Biosciences fundamentals help investors to digest information that contributes to Pressure Biosciences' financial success or failures. It also enables traders to predict the movement of Pressure OTC Stock. The fundamental analysis module provides a way to measure Pressure Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pressure Biosciences otc stock.
Pressure |
Pressure Biosciences OTC Stock Cash Per Share Analysis
Pressure Biosciences' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Pressure Biosciences Cash Per Share | 0.01 X |
Most of Pressure Biosciences' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pressure Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Pressure Biosciences has a Cash Per Share of 0.01 times. This is 99.77% lower than that of the Life Sciences Tools & Services sector and 99.62% lower than that of the Health Care industry. The cash per share for all United States stocks is 99.8% higher than that of the company.
Pressure Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pressure Biosciences' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pressure Biosciences could also be used in its relative valuation, which is a method of valuing Pressure Biosciences by comparing valuation metrics of similar companies.Pressure Biosciences is currently under evaluation in cash per share category among its peers.
Pressure Fundamentals
| Return On Asset | -0.93 | ||||
| Operating Margin | (3.18) % | ||||
| Current Valuation | 33.23 M | ||||
| Shares Outstanding | 11.07 M | ||||
| Shares Owned By Insiders | 1.27 % | ||||
| Shares Owned By Institutions | 0.05 % | ||||
| Number Of Shares Shorted | 6.34 K | ||||
| Price To Earning | (1.05) X | ||||
| Price To Sales | 9.95 X | ||||
| Revenue | 2 M | ||||
| Gross Profit | 1.06 M | ||||
| EBITDA | (5.59 M) | ||||
| Net Income | (20.15 M) | ||||
| Cash And Equivalents | 121.57 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 150 K | ||||
| Debt To Equity | 2.04 % | ||||
| Current Ratio | 0.07 X | ||||
| Book Value Per Share | (2.44) X | ||||
| Cash Flow From Operations | (4.87 M) | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | (2.59) X | ||||
| Target Price | 1.57 | ||||
| Number Of Employees | 12 | ||||
| Beta | 0.73 | ||||
| Market Capitalization | 23.22 M | ||||
| Total Asset | 2.83 M | ||||
| Retained Earnings | (81.02 M) | ||||
| Working Capital | 9.2 M | ||||
| Current Asset | 13.07 M | ||||
| Current Liabilities | 3.88 M | ||||
| Z Score | 53.5 | ||||
| Net Asset | 2.83 M |
About Pressure Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pressure Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pressure Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pressure Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Pressure Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pressure Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pressure Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Pressure OTC Stock
Moving against Pressure OTC Stock
| 0.9 | NXL | Nexalin Technology | PairCorr |
| 0.88 | PEN | Penumbra | PairCorr |
| 0.86 | ELMD | Electromed | PairCorr |
| 0.85 | ECOR | Electrocore LLC | PairCorr |
| 0.74 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to Pressure Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pressure Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pressure Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pressure Biosciences to buy it.
The correlation of Pressure Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pressure Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pressure Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pressure Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |